SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019165
Filing Date
2023-05-09
Accepted
2023-05-09 08:20:19
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20230331.htm   iXBRL 10-Q 2221280
2 EX-31.1 rlyb-ex31_1.htm EX-31 20991
3 EX-31.2 rlyb-ex31_2.htm EX-31 21234
4 EX-32.1 rlyb-ex32_1.htm EX-32 12189
5 EX-32.2 rlyb-ex32_2.htm EX-32 12187
6 GRAPHIC img115698922_0.jpg GRAPHIC 8945
  Complete submission text file 0000950170-23-019165.txt   6737979

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20230331_def.xml EX-101.DEF 165523
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20230331_cal.xml EX-101.CAL 31428
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20230331_lab.xml EX-101.LAB 369208
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20230331_pre.xml EX-101.PRE 284396
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20230331.xsd EX-101.SCH 36275
48 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20230331_htm.xml XML 991944
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 23900099
SIC: 2834 Pharmaceutical Preparations